QSimulate, a portfolio company of Abies Ventures, announces a partnership with Mitsui & Co. and Quantinuum to jointly promote “QIDO,” a Quantum Technology-Based Drug Discovery and Materials Development Platform.
Aug. 20, 2025
- Media
- News
QSimulate, a portfolio company of Abies Ventures, announced a partnership with Mitsui & Co., Ltd. and Quantinuum.
Through this partnership, the companies will develop a new platform, “QIDO (Quantum-Integrated Drug Discovery & Optimization),” that integrates quantum computing and molecular simulation, with the aim of significantly improving the speed and efficiency of drug discovery and new materials discovery.
For more details, please visit the official QSimulate news page.